KLRC1 and type 1 diabetes mellitus: Expression of NKG2A is known to suppress the cytolytic potential of NK cells against activated T cells including autoreactive clones, and we suggest that the expansion of the CD8+NKG2A+ subset in T1D may further intensify a diabetogenic immune response.